This site is intended for health professionals only

Editor’s pick

Fake drugs “are top public concern”
Fake drugs “are top public concern”
Body defences used to battle bugs
Body defences used to battle bugs
Nice bans Nexavar liver-cancer drug
Nice bans Nexavar liver-cancer drug
Morphine “may make cancers worse”
Morphine “may make cancers worse”
BIA appoints Director in Scotland
BIA appoints Director in Scotland
NicOx announces FDA accepts naproxcinod NDA for filing
NicOx announces FDA accepts naproxcinod NDA for filing
NicOx launches a private placement with the participation of the French FSI
NicOx launches a private placement with the participation of the French FSI
Boehringer and GSK back EFA’s call for urgent improvements in care for people with lung disease
Boehringer and GSK back EFA’s call for urgent improvements in care for people with lung disease
NicOx’s successful private placement raises €30 million
NicOx’s successful private placement raises €30 million
Immune system activated in schizophrenia
Immune system activated in schizophrenia
Ceramic implant for woman’s skull
Ceramic implant for woman’s skull
Arthritis “healing” advert banned
Arthritis “healing” advert banned
1 … 99 100 101 102 103 … 302





Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine
Subscribe
FOLLOW US

IMPORTANT LINKS

MORE FROM COGORA

© Cogora 2026
Cogora Limited. 1 Giltspur Street, London EC1A 9DD Registered in the United Kingdom. Reg. No. 2147432

Cogora
x